8-K ·Filed Apr 2, 2026

ILMN

ILLUMINA, INC.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001110803-26-000082
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Monitor the upcoming annual meeting for shareholder sentiment on board changes. David King’s nomination suggests a continued focus on healthcare commercialization and regulatory strategy, which may influence future governance and operational direction.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ILMN ▲ +42.17% at T+60d
NEUTRAL call ✓ call won +42.17% · α vs SPY +29.18% · entry $127.39 → $181.10
Entry anchored
Apr 1, 03:59 PM ET
via exchange tick
T+1d
-0.03%
call -0.03% · α -0.51%
$127.35
settled 6mo ago
T+5d
-5.39%
call -5.39% · α -9.01%
$120.52
settled 6mo ago
T+20d
-0.51%
call -0.51% · α -10.38%
$126.74
settled 5mo ago
T+60d
+42.17%
call +42.17% · α +29.18%
$181.10
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Illumina announced that three board members—Drs. Frances Arnold, Robert S. Epstein, and Gary S. Guthart—will retire at the 2026 annual meeting, and David P. King has been nominated to join the board. The departures are described as retirements with no disputes, and King brings extensive healthcare leadership experience.

Key Facts

  • Drs. Frances Arnold, Robert S. Epstein, and Gary S. Guthart are retiring from Illumina's Board of Directors effective May 21, 2026.
  • The retirements are not due to any disagreement with the company.
  • David P. King, former CEO of LabCorp and current board chair at Privia Health and AmSurg, has been nominated to replace them.
  • The changes will be voted on at the 2026 annual meeting of stockholders.

Financial Impact

No direct financial impact disclosed. Board refreshment expected to support long-term strategy.

Risk Factors

  • Potential loss of scientific and technical expertise from departing directors, particularly Dr. Arnold, a Nobel laureate in chemistry.
  • Transition risk if new director does not integrate smoothly into board dynamics.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments

Investment Themes

Genomics & Gene Editing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001110803-26-000082
Exhibit: ex991pressrelease4226.htm0001110803-26-000082
Document: 0001110803-26-000082-index-headers.html0001110803-26-000082
Document: 0001110803-26-000082-index.html0001110803-26-000082
Document: 0001110803-26-000082.txt0001110803-26-000082
14 reports for ILMN
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +33.30%May 14, 2026
Filters
Rows
Reports for ILMN — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$215.59 $271.90▲ +26.12%▲ +25.86%$273.04 (+26.65%)
Aug 21, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$223.22 $239.62▼ −7.35%▼ −7.33%$273.04 (−22.32%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$188.29 $227.46▲ +20.80%▲ +21.79%$273.04 (+45.01%)
Aug 12, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$192.91 $201.27▲ +4.33%▲ +6.23%$273.04 (+41.54%)
Aug 6, 2026
8w ago
Insider Cluster
BEARISH ★ 6/10
$193.72 $220.65▼ −13.90%▼ −13.30%$273.04 (−40.95%)
Aug 6, 2026
8w ago
Insider Cluster
BEARISH ★ 6/10
$192.37 $220.65▼ −14.70%▼ −14.10%$273.04 (−41.94%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$162.32 $194.33▲ +19.72%▲ +17.86%$273.04 (+68.21%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$161.83 $183.89▲ +13.63%▲ +15.45%$273.04 (+68.72%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$161.83 $183.89▲ +13.63%▲ +15.45%$273.04 (+68.72%)
May 28, 2026
18w ago
Court Ruling
BEARISH ★ 5/10
$157.81 $177.65▼ −12.57%▼ −15.26%$273.04 (−73.02%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (65h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access